Abnormal cervical curvature
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of masticatory muscle
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Airway Obstruction
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Our findings suggest that rs1051730 in CHRNA is a susceptibility variant for COPD, in terms of both airway obstruction and parenchyma destruction.
|
22176972 |
2011 |
Akinesia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ankle weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Aplasia of muscle
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Arthrogryposis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Autistic Disorder
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Blepharoptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Bulbar palsy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Byzanthine arch palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Carcinoma of lung
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Recent genome wide association (GWA) studies on European and American populations revealed association with lung cancer risk of single-nucleotide polymorphisms (SNPs) in the locus containing two nicotine acetylcholine receptor (CHRNA) genes, whose involvement in tobacco addiction had been indicated.
|
19005185 |
2009 |
Carcinoma of lung
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine.
|
19010884 |
2008 |
Carcinoma of lung
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Recent genome-wide association studies in Caucasians revealed association with lung cancer risk of single nucleotide polymorphisms (SNPs) in the locus containing two nicotine acetylcholine receptor CHRNA genes.
|
20234319 |
2010 |
Carcinoma of lung
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Seven SNPs in three nAChR genes were significantly associated with lung cancer at a strict Bonferroni-corrected level, including a novel association on chromosome 2 near the promoter of CHRNA1 (rs3755486: OR = 1.40, 95% CI = 1.18-1.67, P = 1.0 x 10-4).
|
23232035 |
2012 |
Carcinoma of lung
|
0.050 |
Biomarker
|
disease |
BEFREE |
Our results confirm that this CHRNA region is associated with both lung cancer development and smoking behavior.
|
23094028 |
2012 |
Chronic Obstructive Airway Disease
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Herein, we performed a meta-analysis to clarify the impact of CHRNA variants on COPD.
|
22176972 |
2011 |
Chronic Obstructive Airway Disease
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The rs6495309C > T polymorphism in the promoter of nicotinic acetylcholine receptor alpha subunit 3 (CHRNA3) gene was investigated in a case-control study that consisted of 406 patients with COPD and 394 healthy control subjects.
|
23255854 |
2012 |
Cirrhosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
A novel signaling pathway: fibroblast nicotinic receptor alpha1 binds urokinase and promotes renal fibrosis.
|
19690163 |
2009 |
Cleft Palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Clumsiness - motor delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital Epicanthus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital hypoplasia of lung
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cyanosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Decreased miniature endplate potentials
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|